Ashley Brooks

1.2k total citations · 1 hit paper
12 papers, 927 citations indexed

About

Ashley Brooks is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ashley Brooks has authored 12 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Ashley Brooks's work include Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmacology and Obesity Treatment (2 papers). Ashley Brooks is often cited by papers focused on Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmacology and Obesity Treatment (2 papers). Ashley Brooks collaborates with scholars based in United Kingdom, United States and Denmark. Ashley Brooks's co-authors include David Kallend, Amy Simon, Jay D. Horton, Kevin Fitzgerald, Brian R. Bettencourt, Jörg Täubel, Anna Borodovsky, Robert S. Kauffman, Valerie A. Clausen and Peter Wijngaard and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Scientific Reports.

In The Last Decade

Ashley Brooks

12 papers receiving 909 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

2016 586 citations Kevin Fitzgerald, Anna Borodovsky et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Brooks United Kingdom	8	377	370	269	119	117	12	927
Randall B. Graham United States	9	821 2.2×	316 0.9×	154 0.6×	132 1.1×	165 1.4×	14	1.4k
Gabriel P. Lasala United Kingdom	10	690 1.8×	266 0.7×	388 1.4×	161 1.4×	184 1.6×	14	1.0k
Takeshi Kujiraoka Japan	20	506 1.3×	231 0.6×	355 1.3×	185 1.6×	155 1.3×	26	885
Mitsuaki Ishihara Japan	13	327 0.9×	156 0.4×	231 0.9×	117 1.0×	110 0.9×	21	623
Renate M. Hoogeveen Netherlands	10	374 1.0×	137 0.4×	74 0.3×	120 1.0×	211 1.8×	19	705
Federica Basso United States	13	545 1.4×	314 0.8×	156 0.6×	152 1.3×	76 0.6×	20	941
William J. Cain United States	12	971 2.6×	415 1.1×	398 1.5×	353 3.0×	211 1.8×	19	1.3k
Esther Merki United States	10	531 1.4×	479 1.3×	133 0.5×	149 1.3×	241 2.1×	10	1.1k
Roland P.T. Troquay Netherlands	5	568 1.5×	225 0.6×	141 0.5×	148 1.2×	174 1.5×	6	820
Johan G. Schnitzler Netherlands	12	356 0.9×	149 0.4×	94 0.3×	145 1.2×	190 1.6×	15	701

Countries citing papers authored by Ashley Brooks

Since Specialization

Citations

This map shows the geographic impact of Ashley Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Brooks more than expected).

Fields of papers citing papers by Ashley Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Brooks. The network helps show where Ashley Brooks may publish in the future.

Co-authorship network of co-authors of Ashley Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Brooks. A scholar is included among the top collaborators of Ashley Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Brooks. Ashley Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Mori, Mateus Prates, Oswaldo A. Lozoya, Ashley Brooks, et al.. (2025). Mitochondrial membrane hyperpolarization modulates nuclear DNA methylation and gene expression through phospholipid remodeling. Nature Communications. 16(1). 4029–4029. 3 indexed citations

Lee, Dae Young, et al.. (2023). Safety, tolerability, and pharmacokinetics of single and multiple ascending Oral doses of DA‐8010 in healthy subjects: First‐in‐human phase I study. Pharmacology Research & Perspectives. 11(1). e01040–e01040. 3 indexed citations

Pascual, Florencia, Mert Icyuz, Peer W. F. Karmaus, et al.. (2023). Cholesterol biosynthesis modulates differentiation in murine cranial neural crest cells. Scientific Reports. 13(1). 7073–7073. 3 indexed citations

Aslanis, Vassilios, Robert J. Slack, Alison C. MacKinnon, et al.. (2023). Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer Chemotherapy and Pharmacology. 91(3). 267–280. 25 indexed citations

Mulatero, Paolo, Michael Groessl, Bruno Vogt, et al.. (2023). CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone‐to‐renin ratio, an indicator of sodium retention, in healthy volunteers. British Journal of Clinical Pharmacology. 89(8). 2483–2496. 18 indexed citations

Dahl, Kirsten, Ashley Brooks, Firas Almazedi, et al.. (2021). Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 23(7). 1594–1603. 61 indexed citations

Höchel, Joachim, Olaf Prien, Torsten Zimmermann, et al.. (2018). Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential. Clinical Pharmacokinetics. 57(8). 1001–1015. 25 indexed citations

Hjerpsted, Julie, et al.. (2017). Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity. Diabetes Obesity and Metabolism. 20(3). 610–619. 170 indexed citations

Brooks, Ashley, et al.. (2016). SNP Miniplexes for Individual Identification of Random‐Bred Domestic Cats. Journal of Forensic Sciences. 61(3). 594–606. 10 indexed citations

10.

Fitzgerald, Kevin, Anna Borodovsky, Brian R. Bettencourt, et al.. (2016). A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. New England Journal of Medicine. 376(1). 41–51. 586 indexed citations breakdown →

11.

Hjerpsted, Julie, et al.. (2016). Semaglutide Improves Postprandial Glucose and Lipid Metabolism and Delays First-Hour Gastric Emptying in Subjects with Obesity. Canadian Journal of Diabetes. 40(5). S34–S35. 4 indexed citations

12.

Gelderen, Marcel van, Reiner Tretter, John Meijer, et al.. (2014). Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men. International Journal of Clinical Pharmacology and Therapeutics. 52(8). 693–701. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact